Literature DB >> 18542765

Malignant spinal cord compression secondary to testicular seminoma at the time of initial presentation and at relapse while on surveillance.

Don Yee1, Zsolt Gabos, Scott North, Ronald B Moore.   

Abstract

We report cases of 2 pure seminoma patients who developed metastatic spinal cord compressions. One patient was diagnosed at age 33 years with stage 1 seminoma and, after undergoing an orchidectomy, chose to be followed on a surveillance protocol. He was lost to follow-up and presented again 22 months later with back pain, leg weakness and sensory loss when his disease recurred as a spinal cord compression. He was treated with urgent surgical decompression and subsequent standard chemotherapy. More than 2 years posttreatment, he is disease-free with normal neurologic function in his lower extremities. The second patient presented at age 44 years with back pain and rapid loss of leg strength and sensation. Investigations revealed a malignant cord compression with lymphatic and vertebral body metastases. On physical examination, the patient was found to have a 6-cm left testicular mass. He was treated with emergency radiotherapy to the region of his cord compression followed by a left inguinal orchidectomy. Pathology confirmed a pure classic seminoma. Postoperatively, he received standard chemotherapy and eventually regained neurologic function in his legs. Although it is rare for malignant spinal cord compression to occur in seminoma patients-either as the initial presentation of disease or as a site of disease recurrence in stage 1 patients on surveillance-it is crucial to consider seminoma as a possible etiology in young men diagnosed with malignant spinal cord compression because timely contemporary treatments for seminoma will cure most of these patients and offer them excellent functional recovery.

Entities:  

Year:  2007        PMID: 18542765      PMCID: PMC2422929          DOI: 10.5489/cuaj.41

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  10 in total

1.  Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.

Authors:  Roy A Patchell; Phillip A Tibbs; William F Regine; Richard Payne; Stephen Saris; Richard J Kryscio; Mohammed Mohiuddin; Byron Young
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Clinical approach to metastatic epidural spinal cord compression.

Authors:  Young Kwok; Phillip A Tibbs; Roy A Patchell
Journal:  Hematol Oncol Clin North Am       Date:  2006-12       Impact factor: 3.722

3.  Malignant spinal cord compression: prospective study of delays in referral and treatment.

Authors:  D J Husband
Journal:  BMJ       Date:  1998-07-04

Review 4.  Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group.

Authors:  D Andrew Loblaw; James Perry; Alexandra Chambers; Normand J Laperriere
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

5.  Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.

Authors:  Richard Choo; Gillian Thomas; Tony Woo; David Lee; Brian Kong; Neil Iscoe; Cyril Danjoux; Laurie Klotz; Gerard Morton; Sarat Chander
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

6.  Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.

Authors:  Dirk Rades; Fabian Fehlauer; Rainer Schulte; Theo Veninga; Lukas J A Stalpers; Hiba Basic; Amira Bajrovic; Peter J Hoskin; Silke Tribius; Ingeborg Wildfang; Volker Rudat; Rita Engenhart-Cabilic; Johann H Karstens; Winfried Alberti; Juergen Dunst; Steven E Schild
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

7.  Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Authors:  R T D Oliver; M D Mason; G M Mead; H von der Maase; G J S Rustin; J K Joffe; R de Wit; N Aass; J D Graham; R Coleman; S J Kirk; S P Stenning
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

Review 8.  Testicular germ-cell cancer.

Authors:  Alan Horwich; Janet Shipley; Robert Huddart
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

9.  Surveillance following orchidectomy for stage I seminoma of the testis.

Authors:  H von der Maase; L Specht; G K Jacobsen; A Jakobsen; E L Madsen; M Pedersen; M Rørth; H Schultz
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

10.  Stage I testicular seminoma: results of adjuvant irradiation and surveillance.

Authors:  P Warde; M K Gospodarowicz; T Panzarella; C N Catton; J F Sturgeon; M Moore; P Goodman; M A Jewett
Journal:  J Clin Oncol       Date:  1995-09       Impact factor: 44.544

  10 in total
  5 in total

1.  Acute cord compression secondary to spinal relapse of testicular seminomas.

Authors:  Yau Hong Ng; Henry Sun Sien Ho; Naresh Satyanarayan Kumar
Journal:  BMJ Case Rep       Date:  2013-04-17

2.  Testicular cancer in Down syndrome with spinal cord metastases.

Authors:  Turky Almouhissen; Hattan Badr; Bassam AlMatrafi; Noor Alessa; Anmar Nassir
Journal:  Urol Ann       Date:  2016 Oct-Dec

3.  Malignant Spinal Cord Compression Syndrome as an Initial Presentation of Testicular Cancer.

Authors:  Carlos Eduardo Salazar-Mejía; Edio Llerena-Hernández; David Hernández-Barajas; Oscar Vidal-Gutiérrez; Adriana González-Gutiérrez; Rolando Jacob Martínez-Granados; Blanca Otilia Wimer-Castillo
Journal:  Case Rep Oncol Med       Date:  2018-10-08

4.  Isolated femoral muscle and bone metastases rarely encountered in testicular seminoma.

Authors:  Serkan Degirmencioglu; Burcu Degirmencioglu
Journal:  Case Rep Oncol Med       Date:  2013-05-12

5.  Primary Extramedullary, Extradural Cervical Spine Seminoma.

Authors:  Charles Long; Thomas A Novack; Stuart Changoor; Kumar Sinha; Ki Soo Hwang; Michael J Faloon; Arash Emami
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.